Persistent generalized anxiety after brief exposure to the dopamine antagonist metoclopramide. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.

The role of drug therapy in social phobia. Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. Effects of a brief behavioral treatment for PTSD-related sleep disturbances: a pilot study.

Welcome! https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly93d3cubWVkc2NhcGUuY29tL2Fuc3dlcnMvMjg2MjI3LTE4MzYwL3doaWNoLW1lZGljYXRpb25zLWluLXRoZS1kcnVnLWNsYXNzLWFudGlwc3ljaG90aWMtYWdlbnQtYXJlLXVzZWQtaW4tdGhlLXRyZWF0bWVudC1vZi1hbnhpZXR5LWRpc29yZGVycw==


A randomized, double-blind clinical trial controlled with lorazepam. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Antipsychotics are typically used for a short time while the symptoms are active.

Lewis C, Pearce J, Bisson JI. Strug LJ, Suresh R, Fyer AJ, Talati A, Adams PB, Li W, et al. Structure of genetic and environmental risk factors for dimensional representations of DSM-IV anxiety disorders.

Anxiety. Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A. Functional impairment in social phobia. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Virtual reality exposure therapy and standard (in vivo) exposure therapy in the treatment of fear of flying.



Antipsychotic AgentAtypical and typical antipsychotic medications are generally used more as augmentation strategies and are second-line treatment options in generalized anxiety disorder.

Psychotherapy in the overall management strategy for social anxiety disorder.

Nitschke JB, Sarinopoulos I, Oathes DJ, Johnstone T, Whalen PJ, Davidson RJ. Cigarette smoking and 35% CO(2) induced panic in panic disorder patients.

Take this short survey so Cochrane can better meet your needs in the future. Barlow JH, Ellard DR, Hainsworth JM, Jones FR, Fisher A. The current study provides an updated meta-analytic review of their efficacy and potential guidelines for their application in SAD. Also possesses antiserotonergic (5-HT1c, 5-HT2, 5-HT3) properties.

Quality of life in anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder. Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up. This We identified eligible trials on quetiapine, risperidone and olanzapine. Tambs K, Czajkowsky N, Røysamb E, Neale MC, Reichborn-Kjennerud T, Aggen SH. Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: systematic review.

Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. Sareen J, Cox BJ, Afifi TO, de Graaf R, Asmundson GJ, ten Have M. Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults.

Litz BT, Engel CC, Bryant RA, Papa A. Fyer AJ, Mannuzza S, Chapman TF, Liebowitz MR, Klein DF. Barclay TH, Barclay RD. 2001 May inhibit serotonin, muscarinic, and dopamine effects. Evidence based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Ayala ES, Meuret AE, Ritz T. Treatments for blood-injury-injection phobia: a critical review of current evidence.

Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. Chart showing the female-to-male sex ratio for anxiety disorders. American Psychiatric Association. Mental health treatment received by primary care patients with posttraumatic stress disorder.

Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder.

Uhlenhuth EH, Balter MB, Ban TA, Yang K. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Lydiard RB.


Dratcu L. Panic, hyperventilation and perpetuation of anxiety. Lochner C, Mogotsi M, du Toit PL, Kaminer D, Niehaus DJ, Stein DJ. Washington (DC): American Psychiatric Association (APA); 2009 Jan. Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, et al. Neuroimaging in social anxiety disorder: a systematic review of the literature. Karno M, Golding JM, Sorenson SB, Burnam MA.



Except for trifluoperazine, there is no large, well-designed study of antipsychotics in the treatment of primary or comorbid anxiety symptoms or disorders.

González-Berríos N. Sertraline-induced panic attack.



Allgulander C. Paroxetine in social anxiety disorder: a randomized placebo-controlled study.

Advances in molecular genetics of panic disorder.